|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 5 of 13 found articles
| Title: |
Clinical trials and drug promotion: Selective reporting of study 329 |
| Author: |
Jureidini, Jon N. McHenry, Leemon B. Mansfield, Peter R. |
| Appeared in: |
International journal of risk & safety in medicine |
| Paging: | Volume 20 (2008) nr. 1-2 pages 73-81 |
| Year: |
2008-04-11 |
| Contents: |
Selective reporting is prevalent in the medical literature, particularly in industry-sponsored research. In this paper, we expose selective reporting that is not evident without access to internal company documents. The published report of study 329 of paroxetine in adolescents sponsored by GlaxoSmithKline claims that “paroxetine is generally well tolerated and effective for major depression in adolescents”. By contrast, documents obtained during litigation reveal that study 329 was negative for efficacy on all 8 protocol specified outcomes and positive for harm. |
| Publisher: |
IOS Press |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 5 of 13 found articles
| << previous | next >> |